Characterization of SPINK9, a KLK5-specific inhibitor expressed in palmo-plantar epidermis

Biological Chemistry

Volumn 393, Issue 5, 2012, Pages 369-377

  Brännström, Kristoffer ^a   Öhman, Anders ^a   Von Pawel Rammingen, Ulrich ^a   Olofsson, Anders ^a   Brattsand, Maria ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Binding studies; Inhibition; Kallikrein related peptidases; Kazal type inhibitor; KLK5; SPINK9

Indexed keywords

HISTIDINE; KALLIKREIN; KALLIKREIN 14; KALLIKREIN 5; METHIONINE; NEUROPSIN; SERINE PROTEINASE INHIBITOR; SPINK9 SERINE PROTEINASE INHIBITOR; STRATUM CORNEUM CHYMOTRYPTIC ENZYME; TRYPSIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME BINDING; ENZYME DEGRADATION; ENZYME INHIBITION; EPIDERMIS; GLYCOSYLATION; HUMAN; HUMAN CELL; HYDROGEN BOND; HYDROPHOBICITY; IN VITRO STUDY; MUTAGENESIS; PH; PLANTARIS MUSCLE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN SURFACE; STATIC ELECTRICITY;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; EPIDERMIS; FOOT; GENE EXPRESSION REGULATION; HAND; HUMANS; KALLIKREINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEASE INHIBITORS; PROTEIN CONFORMATION; PROTEINASE INHIBITORY PROTEINS, SECRETORY; SUBSTRATE SPECIFICITY;

EID: 84859854250     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2011-0238     Document Type: Conference Paper

References (45)

1. Arnold, K., Bordoli, L., Kopp, J., and Schwede, T. (2006). The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22, 195-201. (Pubitemid 43205406)
2. Benkert, P., Biasini, M., and Schwede, T. (2011). Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics 27, 343-350.
3. Borgoño, C.A., Michael, I.P., Komatsu, N., Jayakumar, A., Kapadia, R., Clayman, G.L., Sotiropoulou, G., and Diamandis, E.P. (2007). A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J. Biol. Chem. 282, 3640-3652. (Pubitemid 47084449)
4. Brattsand, M. and Egelrud, T. (1999). Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J. Biol. Chem. 274, 30033-30040.
5. Brattsand, M., Stefansson, K., Lundh, C., Haasum, Y., and Egelrud, T. (2005). A proteolytic cascade of kallikreins in the stratum corneum. J. Invest. Dermatol. 124, 198-203. (Pubitemid 40100969)
6. Brattsand, M., Stefansson, K., Hubiche, T., Nilsson, S.K., and Egelrud, T. (2009). SPINK9: a selective, skin-specific Kazal-type serine protease inhibitor. J. Invest. Dermatol. 129, 1656-1665.
7. Burns, T., Breathnach, S., Cox, N., and Griffiths, C., eds. (2004). Rook's Textbook of Dermatology (Blackwell Publishing).
8. Caubet, C., Jonca, N., Brattsand, M., Guerrin, M., Bernard, D., Schmidt, R., Egelrud, T., Simon, M., and Serre, G. (2004). Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/ KLK7/hK7. J. Invest. Dermatol. 122, 1235-1244. (Pubitemid 38651099)
9. Chavanas, S., Bodemer, C., Rochat, A., Hamel-Teillac, D., Ali, M., Irvine, A., Bonafé, J., Wilkinson, J., Taïeb, A., Barrandon, Y., et al. (2000). Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat. Genet. 25, 141-142. (Pubitemid 30394980)
10. Cork, M.J., Danby, S.G., Vasilopoulos, Y., Hadgraft, J., Lane, M.E., Moustafa, M., Guy, R.H., Macgowan, A.L., Tazi-Ahnini, R., and Ward, S.J. (2009). Epidermal barrier dysfunction in atopic dermatitis. J. Invest. Dermatol. 129, 1892-1908.
11. Debela, M., Goettig, P., Magdolen, V., Huber, R., Schechter, N.M., and Bode, W. (2007). Structural basis of the zinc inhibition of human tissue kallikrein 5. J. Mol. Biol. 373, 1017-1031. (Pubitemid 47498441)
12. Deraison, C., Bonnart, C., Lopez, F., Besson, C., Robinson, R., Jayakumar, A., Wågberg, F., Brattsand, M., Hachem, J.P., Leonardsson, G., et al. (2007). LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol. Biol. Cell 18, 3607-3619. (Pubitemid 47378698)
13. Descargues, P., Deraison, C., Prost, C., Fraitag, S., Mazereeuw- Hautier, J., D'Alessio, M., Ishida-Yamamoto, A., Bodemer, C., Zambruno, G., and Hovnanian, A. (2006). Corneodesmosomal cadherins are preferential targets of stratum corneum trypsinand chymotrypsin-like hyperactivity in Netherton syndrome. J. Invest. Dermatol. 126, 1622-1632.
14. Eissa, A., Amodeo, V., Smith, C.R., and Diamandis, E.P. (2011). Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade. J. Biol. Chem. 286, 687-706.
15. Felber, L.M., Kundig, C., Borgoño, C.A., Chagas, J.R., Tasinato, A., Jichlinski, P., Gygi, C.M., Leisinger, H.J., Diamandis, E.P., Deperthes, D., et al. (2006). Mutant recombinant serpins as highly specific inhibitors of human kallikrein 14. FEBS J. 273, 2505-2514. (Pubitemid 43736662)
16. Guex, N. and Peitsch, M.C. (1997). SWISS-MODEL and the Swiss- PdbViewer: an environment for comparative protein modeling. Electrophoresis 18, 2714-2723. (Pubitemid 28059943)
17. Hanson, K.M., Behne, M.J., Barry, N.P., Mauro, T.M., Gratton, E., and Clegg, R.M. (2002). Two-photon fluorescence lifetime imaging of the skin stratum corneum pH gradient. Biophys. J. 83, 1682-1690. (Pubitemid 34977738)
18. Hansson, L., Strömqvist, M., Bäckman, A., Wallbrandt, P., Carlstein, A., and Egelrud, T. (1994). Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J. Biol. Chem. 269, 19420-19426.
19. Harvey, T., Hooper, J., Myers, S., Stephenson, S., Ashworth, L., and Clements, J. (2000). Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4. J. Biol. Chem. 275, 37397-37406. (Pubitemid 32004843)
20. Ibrahim, B.S. and Pattabhi, V. (2004). Crystal structure of trypsinturkey egg white inhibitor complex. Biochem. Biophys. Res. Commun. 313, 8-16. (Pubitemid 37524017)
21. Jalkanen, J., Kotimaki, M., Huhtaniemi, I., and Poutanen, M. (2006). Novel epididymal protease inhibitors with Kazal or WAP family domain. Biochem. Biophys. Res. Commun. 349, 245-254. (Pubitemid 44331788)
22. Komatsu, N., Takata, M., Otsuki, N., Ohka, R., Amano, O., Takehara, K., and Saijoh, K. (2002). Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J. Invest. Dermatol. 118, 436-443. (Pubitemid 34227160)
23. Komatsu, N., Saijoh, K., Jayakumar, A., Clayman, G.L., Tohyama, M., Suga, Y., Mizuno, Y., Tsukamoto, K., Taniuchi, K., Takehara, K., et al. (2008). Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients. J. Invest. Dermatol. 128, 1148-1159. (Pubitemid 351543199)
24. Koradi, R., Billeter, M., and Wüthrich, K. (1996). MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph 14, 51-55, 29-32. (Pubitemid 26152976)
25. Kunitz, M. (1947). Crystalline soybean trypsin inhibitor 2. General properties. J. Gen. Physiol. 30, 291-310.
26. Lai, Y. and Gallo, R.L. (2009). AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 30, 131-141.
27. Li, H., Robertson, A.D., and Jensen, J.H. (2005). Very fast empirical prediction and rationalization of protein pKa values. Proteins 61, 704-721. (Pubitemid 41753142)
28. Mägert, H.J., Standker, L., Kreutzmann, P., Zucht, H.D., Reinecke, M., Sommerhoff, C.P., Fritz, H., and Forssmann, W.G. (1999). LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J. Biol. Chem. 274, 21499-21502.
29. Meyer-Hoffert, U., Wu, Z., and Schröder, J.M. (2009). Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor. PLoS ONE 4, e4372.
30. Meyer-Hoffert, U., Wu, Z., Kantyka, T., Fischer, J., Latendorf, T., Hansmann, B., Bartels, J., He, Y., Glaser, R., and Schröder, J.M. (2010). Isolation of SPINK6 in human skin: selective inhibitor of kallikrein-related peptidases. J. Biol. Chem. 285, 32174-32181.
31. Netherton, E.W. (1958). A unique case of trichorrhexis nodosa; bamboo hairs. AMA Arch. Derm. 78, 483-487.
32. Ohler, A., Debela, M., Wagner, S., Magdolen, V., and Becker-Pauly, C. (2010). Analyzing the protease web in skin: meprin metalloproteases are activated specifically by KLK4, 5 and 8 vice versa leading to processing of proKLK7 thereby triggering its activation. Biol. Chem. 391, 455-460.
33. Öhman, H. and Vahlquist, A. (1994). In vivo studies concerning a pH gradient in human stratum corneum and upper epidermis. Acta. Derm. Venereol. 74, 375-379. (Pubitemid 24305854)
34. Oikonomopoulou, K., Hansen, K.K., Saifeddine, M., Vergnolle, N., Tea, I., Blaber, M., Blaber, S.I., Scarisbrick, I., Diamandis, E.P., and Hollenberg, M.D. (2006). Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs). Biol. Chem. 387, 817-824. (Pubitemid 43964807)
35. Olsson, M.H.M., Sondergaard, C.R., Rostkowski, M., and Jensen, J.H. (2011). PROPKA3: consistent treatment of internal and surface residues in empirical pK(a) predictions. J. Chem. Theory Comput. 7, 525-537.
36. Peitsch, M.C. (1995). Protein Modeling by E-mail. Nat. Biotechnol. 13, 658-660.
37. Simon, M., Jonca, N., Guerrin, M., Haftek, M., Bernard, D., Caubet, C., Egelrud, T., Schmidt, R., and Serre, G. (2001). Refined characterization of corneodesmosin proteolysis during terminal differentiation of human epidermis and its relationship to desquamation. J. Biol. Chem. 276, 20292-20299.
38. Stefansson, K., Brattsand, M., Ny, A., Glas, B., and Egelrud, T. (2006). Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum. Biol. Chem. 387, 761-768. (Pubitemid 43964798)
39. Stefansson, K., Brattsand, M., Roosterman, D., Kempkes, C., Bocheva, G., Steinhoff, M., and Egelrud, T. (2008). Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases. J. Invest. Dermatol. 128, 18-25. (Pubitemid 350249381)
40. Swedberg, J.E., Nigon, L.V., Reid, J.C., de Veer, S.J., Walpole, C.M., Stephens, C.R., Walsh, T.P., Takayama, T.K., Hooper, J.D., Clements, J.A., et al. (2009). Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4. Chem. Biol. 16, 633-643.
41. Swedberg, J.E., de Veer, S.J., Sit, K.C., Reboul, C.F., Buckle, A.M., and Harris, J.M. (2011). Mastering the canonical loop of serine protease inhibitors: enhancing potency by optimising the internal hydrogen bond network. PLoS ONE 6, e19302.
42. Yamasaki, K., Schauber, J., Coda, A., Lin, H., Dorschner, R., Schechter, N., Bonnart, C., Descargues, P., Hovnanian, A., and Gallo, R. (2006). Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J. 20, 2068-2080. (Pubitemid 44953906)
43. Yamasaki, K., Di Nardo, A., Bardan, A., Murakami, M., Ohtake, T., Coda, A., Dorschner, R.A., Bonnart, C., Descargues, P., Hovnanian, A., et al. (2007). Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat. Med. 13, 975-980. (Pubitemid 47222043)
44. Yoon, H., Laxmikanthan, G., Lee, J., Blaber, S.I., Rodriguez, A., Kogot, J.M., Scarisbrick, I.A., and Blaber, M. (2007). Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J. Biol. Chem. 282, 31852-31864. (Pubitemid 350106429)
45. Yousef, G., Luo, L., and Diamandis, E. (1999). Identification of novel human kallikrein-like genes on chromosome 19q13.3- q13.4. Anticancer Res. 19, 2843-2852. (Pubitemid 30042561)